HK Stock MarketDetailed Quotes

HUA MEDICINE-B (02552)

Watchlist
  • 3.330
  • -0.040-1.19%
Trading May 6 09:52 CST
3.52BMarket Cap2.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HUA MEDICINE-B (02552) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of drugs492.84M99.98%
Service income90K0.02%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of drugs492.84M99.98%
Service income90K0.02%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China492.93M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.87%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +3.17%
4
CNOOC
00883
+2.59%
5
SINOPEC CORP
00386
+1.31%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +54.24%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +42.96%
4
Emdoor Information
001314
+33.15%
5
Business-intelligence Of Oriental Nations Corporation
300166
+26.44%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -